Eric Smith

Director Of Research Development at Marker Therapeutics

Eric Smith, Ph.D. has a diverse work experience in the field of research and development. Eric currently works at Marker Therapeutics, Inc. as the Director of Research Development, where they manage a team of scientists and leads the research and development of novel cell therapy products. Eric is responsible for developing assays to assess cell therapy products, executing pre-clinical studies, and designing new products through pilot projects. Eric works collaboratively with various departments to integrate the needs of R&D, Regulatory, CMC, and Quality groups. Eric also has experience as an Associate Director of Research Development, Principal Scientist, and Senior Scientist at Marker Therapeutics.

Additionally, Eric has worked at CellReady™ as the Director of Research Development and at Baylor College of Medicine as a PHD candidate and Research Assistant. Earlier in their career, they held various positions at Wadsworth Center, including Research Scientist, Assistant Research Scientist, and Senior Lab Technician. Eric was involved in infectious disease research, managed laboratory operations, and supervised students.

Furthermore, Eric has experience as a Research Associate at Albany College of Pharmacy and Health Sciences.

Overall, Eric Smith, Ph.D. has a strong background in research and development, with a focus on cell therapy and infectious disease studies.

Eric Smith, Ph.D. obtained their Bachelor of Science (B.S.) degree in Biochemistry and Biophysics from Rensselaer Polytechnic Institute in 2002. Eric then went on to earn their Doctor of Philosophy (Ph.D.) degree in Molecular and Cellular Biology from Baylor College of Medicine, completing their studies in 2020.

Links

Previous companies

Baylor College of Medicine logo

Org chart

Timeline

  • Director Of Research Development

    January, 2023 - present

  • Associate Director Research Development

    February, 2022

  • Principal Scientist

    July, 2021

  • Senior Scientist

    July, 2020

View in org chart